Latest News- Cancer Biologics Market: Monoclonal antibodies is expected to lead the Product segment during 2025-2029

The Cancer Biologics Market is being driven by Rising global incidence of cancer

The Cancer Biologics Market is expected to grow at a CAGR of 10.7% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 84.5 billion. The global cancer epidemic poses a significant health challenge, particularly in developing countries where the incidence rate is on the rise. Factors such as a large and growing population, an aging demographic, and increased consumption of cancer-causing agents like beetle nuts, tobacco, and alcohol are fueling the demand for cancer treatments in these regions. Major pharmaceutical companies are recognizing the potential of emerging markets in India, China, and Brazil, as they seek to expand their oncology drug portfolios. The burgeoning healthcare sector in these countries, driven by the increasing number of cancer cases, presents a lucrative opportunity for cancer supportive drug manufacturers. 

Get more information on Cancer Biologics Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Product
  • Monoclonal antibodies
  • Cell and gene therapy
  • Vaccines
  • Others
• Route Of Administration
  • Injectable
  • Oral
• Type
  • Breast cancer
  • Lung cancer
  • Colorectal cancer
  • Prostate cancer
  • Others
• Distribution Channel
  • Hospitals
  • Clinics
  • Others
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
  • Asia
    • China
    • India
    • Japan
    • South Korea
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Rising global incidence of cancer
• Increased demand for cancer biologics due to emphasis on personalized medicines
• Significant therapeutic benefits of cancer biologics

However, the market also witnesses some limitations, which are as follows:

• High cost of cancer biologics
• Patent expiry of major cancer biologics
• Late diagnosis and poor survival of patients with cancer

Benefits of Buying Global Cancer Biologics Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Cancer Biologics Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Cancer Biologics Market encompasses innovative treatments derived from Cancer Biotechnology, including targeted therapies. These advanced treatments focus on molecular targets in Cancer Biology, such as Gene Therapy and Cell-Based Immunotherapies. Biologic drugs, derived from living organisms, are a significant part of this market. Traditional chemotherapy contrasts with these advanced treatments. Reimbursement policies and interactions with insurance providers are crucial considerations. Cancer Biologics are available at Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies for Colorectal Cancer patients.

Market Research Overview

The Cancer Biologics Market, a segment of the larger cancer biotechnology industry, focuses on the development and production of biologic drugs, including targeted therapies, for the treatment of various types of cancer. This market is driven by several factors, such as the increasing prevalence of cancer due to an aging population and advancements in cancer biology leading to innovative treatments and molecular targets. Reimbursement policies and regulatory approvals also play a significant role in market growth. According to Technavio's market research, the global pharmaceuticals market, which encompasses manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services, is expected to experience significant growth due to the increasing global population aging, with one-quarter of the US population projected to be over 60 years old by 2050, and Europe reaching a similar population ratio by 2030.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/